risk ratios, odds ratios, survivorship, incidenceprevalence data, cost data, meta-analyses) in an interpretable fashion for Registries and CQV stakeholders, including clinicians who will guide treatment, diagnostic, andor screening recommendations and publications based on the results of these analyses